Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Yeun-Yoon Kim, Mi-Suk Park, Khalid Suliman Aljoqiman, Jin-Young Choi, Myeong-Jin Kim

Clin Mol Hepatol. 2019;25(3):223-233. Published online January 21, 2019

DOI: https://doi.org/10.3350/cmh.2018.0107

View: 10251 Download: 408 Web of Science: 27 Crossref: 29

Ah Yeong Kim, Woo Kyoung Jeong

Clin Mol Hepatol. 2016;22(1):192-197. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.192

View: 11530 Download: 231 Web of Science: 11 Crossref: 13

Woo Kyoung Jeong, Young Kon Kim, Kyoung Doo Song, Dongil Choi, Hyo Keun Lim

Clin Mol Hepatol. 2013;19(4):360-366. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.360

View: 10592 Download: 140 Crossref: 21

Seung Hyun Kim, Woo Kyoung Jeong, Yongsoo Kim, Min Yeong Kim, Jinoo Kim, Ju Yeon Pyo, Young Ha Oh

Clin Mol Hepatol. 2013;19(1):92-96. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.92

View: 7105 Download: 76 Web of Science: 10 Crossref: 11

1 |

Viewed By 5394	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5361	MAFLD: How is it different from NAFLD?
Viewed By 5244	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3924	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3900	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search